ライフサイエンスコーパス: antibody titre

1 and 2.96 [1.89-4.62] for pseudoneutralising antibody titres).

2 ion of antigen specific B cells and enhanced antibody titres.

3 t was an increase of more than four times in antibody titres.

4 elopment and is associated with a decline of antibody titres.

5 ment was associated with a decrease of serum antibody titres.

6 hy survivors have insignificant neutralizing antibody titres.

7 fected animals possess high BLV-neutralizing antibody titres.

8 ategy is to attain a sustained high level of antibody titres.

9 d dose of ChAdOx1 nCoV-19 leads to increased antibody titres.

10 ty in the context of waning or subprotective antibody titres.

11 de, particularly in patients with high PLA2R antibody titres.

12 2 receptor-binding antibody and neutralising antibody titres.

13 concentrations of cytokines, and circulating antibody titres.

14 version, and (1/3) log2 for log2-transformed antibody titres.

15 immunisations to reach the same neutralising antibody titres.

16 ad seroconversion or a four-fold increase in antibody titres.

17 d were correlated with clinical outcomes and antibody titres.

18 ntagonist, BIBP 3226 (30 nmol), and of a NPY antibody (titre 1:24 000, 3 microl) abolished the inhibi

19 m analysis in participants with baseline Ad5 antibody titre 200 or less, 24 (3%) of 741 vaccine recip

20 The primary outcome was geometric mean antibody titre 21 days after vaccination.

21 outcome measure was anti-spike-RBD-specific antibody titre 3 weeks after vaccination and analysis pe

22 binding index (ABI) = 16-64] and 14% had low antibody titres (ABI = 4) after 1 year on treatment.

23 and demonstrate a reduction in neutralizing antibody titres across all groups 6 months post-vaccinat

24 (>=1:8) or four-fold increase in reciprocal antibody titres adjusted for maternal antibody decay and

25 r age group, the geometric mean fold rise in antibody titre after the booster relative to 1 month pos

26 Neutralising antibody titres after a boost dose were similar across a

27 Neutralising antibody titres after a boost dose were similar across a

28 Antibody titres after a single dose measured approximate

29 ants younger than 9 months resulted in lower antibody titres after one or two subsequent doses of MCV

30 ariant, was associated with the neutralising antibody titres after SARS-CoV-2 infection.

31 The antibody titres after vaccination did not differ signifi

32 placebo groups who did not attain protective antibody titres after vaccination, using a one-sided sig

33 Although the antibody titre against gB correlated with protection poo

34 nd durable binding antibody and neutralising antibody titres against a broad panel of SARS-CoV-2 vari

35 The antibody titres against all three poliovirus serotypes w

36 , elicited similar protective neutralization antibody titres against an H3 influenza antigen when com

37 e two shortened regimens elicited comparable antibody titres against autologous clade C Env at peak i

38 esponses generated by these infections using antibody titres against current and historical strains.

39 Neutralising antibody titres against early omicron subvariants and cl

40 cross-reactive haemagglutination-inhibition antibody titres against H5N1 (clades 1, 2.1.3.2, and 2.3

41 n the plant stanol ester group showed higher antibody titres against HAV 3 and 4 wk after vaccination

42 to 2021, we show that the rate of waning of antibody titres against influenza virus during the pande

43 8.3%, 95% CI 5.0-31.1; p<0.0001), and median antibody titres against poliovirus type 2 were 181 (95%

44 Opsonising antibody titres against some isolates were positively co

45 were periodic increases and decreases in HAI antibody titres against three A(H1N1)pdm09 strains, and

46 Neutralising antibody titres against XBB.1.5 were detected after thre

47 s also a significant decline in neutralizing antibody titres against ZIKV, but not against dengue vir

48 ldren < 15 years had the lowest neutralising antibody titres among infected (not vaccinated) particip

49 four-fold higher than the estimated maternal antibody titre and more than or equal to 8 after three v

50 ating gene expression profiles with ZEBOV-GP antibody titres and a gene signatures associated with re

51 ween elevated anti-Chlamydia pneumoniae (Cp) antibody titres and coronary heart disease (CHD) is uncl

52 Both anti-CSP antibody titres and CSP-specific CD4(+) T cells were ide

53 and used the joint distributions of the peak antibody titres and decay rate to estimate population-le

54 immunosorbent assays to measure anti-anthrax antibody titres and developed three increasingly conserv

55 Given the low antibody titres and fast decline in the CoronaVac group

56 ebrovascular territories, plasma anti-AN1792 antibody titres and late cognitive status.

57 in stalk, anti-H2, anti-H9, and anti-H18 IgG antibody titres and plasmablast and memory B-cell respon

58 ost-vaccination peripheral blood anti-AN1792 antibody titres and post-mortem plaque scores (rho = - 0

59 s metric, an age-dependent trade-off between antibody titres and protein reserves emerged, indicating

60 Antibody titres and safety evaluation were used to selec

61 on "high-dose" glucocorticoids (>20 mg/day), antibody titres and seropositivity are reduced, whereas

62 ine mucosal and systemic SARS-CoV-2-specific antibody titres and significantly lower peripheral IFNga

63 The antibody titres and the frequencies of memory B cells, b

64 he association between anti-circumsporozoite antibody titres and the magnitude and duration of vaccin

65 Antibody titres and vaccine effectiveness decline within

66 strating a correlation between AQP4-Ab (AQP4-antibody) titres and the clinical course of disease.

67 (SAB) is influenced by denatured HLA on SAB, antibody titre, and complement interference that causes

68 SARS-CoV-2 IgG, neutralising antibody titres, and antibody avidity were measured in s

69 or equal to four-fold higher than acute sera antibody titres, and convalescent antibody titres of 40

70 rty-three percent of patients developed high antibody titres [antibody binding index (ABI) = 16-64] a

71 some with lower peak ID(50) had neutralizing antibody titres approaching baseline within the follow-u

72 Anti-circumsporozoite antibody titres are a surrogate of protection for the ma

73 Higher antibody titres are associated with higher estimates of

74 Whilst neutralising antibody titres are associated with protection, these ar

75 s is allowed in cases where anti-blood group antibody titres are deemed amenable to removal by aphere

76 Antiglycolipid antibody titres are frequently elevated in sera from the

77 We also show that higher antibody titres are required for treatment of SARS-CoV-2

78 These data demonstrate that relatively low antibody titres are sufficient for protection against SA

79 0% inhibitory dilution (ID(50)) neutralizing antibody titre as a correlate of risk and of protection.

80 whether such assays can predict neutralising antibody titres as antibody levels wane and viral varian

81 restratified by sex, adenovirus type 5 (Ad5) antibody titre at baseline, and study site.

82 esidual memory function was predicted by the antibody titre at presentation.

83 mary outcomes were yellow fever neutralising antibody titres at 4 weeks post-YF-17D vaccination, Salm

84 , anti-SARS-CoV-2 IgG and pseudoneutralising antibody titres at day 28 after the second dose were hig

85 Secondary immunogenicity outcomes are antibody titres at day 28 and percentages of seroconvers

86 ary outcome for immunogenicity was IgG ELISA antibody titres at day 28 in the per-protocol population

87 Secondary outcomes included neutralising antibody titres at day 28, local and systemic reactogeni

88 was defined as post-vaccination neutralising antibody titres at least 4 times pre-vaccination measure

89 e 2 randomised controlled trial, we compared antibody titres at month 36 in participants who had rece

90 ess the increase in mean log-10 neutralising antibody titres between day 29 and day 43 (after the sec

91 infer key immunological parameters, such as antibody titre boosting, waning and cross-reaction, as w

92 85.5-98.8); the geometric mean neutralising antibody titre by PRNT60 was 250 (176-355) and seroconve

93 protein expression, and profoundly increases antibody titre by up to 128 times in mice compared to th

94 including CSF in antibody studies, and that antibody titres can complement clinical assessments.

95 a higher median anti-SARS-CoV-2 neutralizing antibody titre compared with those who did not (298 vers

96 nd significantly lower anti-SARS-CoV-2 spike antibody titres compared to Usual Care.

97 cted-unvaccinated participants, neutralising antibody titres continually declined from 6-month to 2-y

98 raemia after transplantation, glycoprotein-B antibody titres correlated inversely with duration of vi

99 Anti-S antibody titres correlated with the frequency of S-speci

100 e to influenza viruses, combined with waning antibody titres, could result in larger and/or more seve

101 Antibody titres declined more rapidly in participants wi

102 Our results show that maternal antibody titres declined rapidly in neonates, with over

103 Neutralising antibody titres decreased over the first few months post

104 52% of elephants had measurable anti-anthrax antibody titres, depending on the model used.

105 low' (< 1:10,000), the latter similar to the antibody titres detected in some small-cell lung cancer

106 ata to train a machine learning algorithm on antibody titre differences between consecutive years to

107 after the second vaccine dose, neutralizing antibody titres fell 4.9-fold to a median titre of 21.3

108 ighest seropositivity and anti-spike RBD IgG antibody titres, followed by ChAdOx1, and then by Corona

109 oosting upon both the height and duration of antibody titres following primary immunisation.

110 Serum antibody titres for anti-tTG and anti-DGP antibodies inc

111 n=126) or PCV13 (n=237) and opsonophagocytic antibody titre from a subset of these infants (n=100).

112 ects with a specific range of cross-reactive antibody titres from a prior inactivated Japanese enceph

113 Investigators were aware of antibody titres from baseline (enrolment) through month

114 , and yellow fever; and the post-vaccination antibody titres generated against each component of the

115 sally high (>97%) after vaccination, but the antibody titres generated by fractional intradermal dose

116 Serum GAD65 antibody titre >500 nmol/L and cerebellar ataxia predict

117 Cerebellar ataxia and serum GAD65 antibody titre >500 nmol/L predicted poor outcome.

118 fluenza plasma (haemagglutination inhibition antibody titre >=1:80) compared with low-titre plasma (<

119 se (ID(50) > 10,000) maintained neutralizing antibody titres >1,000 at >60 d POS, some with lower pea

120 er a median of 56 days when serum monoclonal antibody titres had declined to undetectable levels, alt

121 cordingly, the geometric mean ratio (GMR) of antibody titres had increased almost 21-fold more in the

122 quently in patients with a pretransplant ABO antibody titre higher than 16 and/or posttransplant ABO

123 imputed infections, we found that individual antibody titres, household composition and antibody titr

124 KL-6 correlated with IgG antibody titre in those with symptoms, r = .591, P = .00

125 ffects observed A(H1N1)pdm09 strain-specific antibody titres in a Chinese paediatric population.

126 icantly increased post two-dose neutralizing antibody titres in both populations.

127 T cell influx and elevated plasma and airway antibody titres in both SIV-infected and naive animals.

128 Antibody titres in CSF and serum were higher in patients

129 l tolerated and elicited robust neutralising antibody titres in healthy adults.

130 n naive mouse models and boosts neutralizing antibody titres in RSV-pre-exposed mice and non-human pr

131 asurement of the hemagglutination inhibition antibody titres in serum for the three viral strains inc

132 Over time there was a decrease of antibody titres in the 35 patients with good or poor out

133 included geometric mean fold rise (GMFR) in antibody titres; incidence of solicited local and system

134 utination inhibition and microneutralisation antibody titres increased significantly with age (F test

135 ,620 (95% CI: 806-3,259), and in both groups antibody titres increased up to day 180.

136 ained on annual haemagglutination inhibition antibody titre inputs, we identified 1,049 infections, 9

137 t serological assays to predict neutralising antibody titres is likely to be crucial for evaluation o

138 ereotactic surgery, and who had an anti-AAV2 antibody titre lower than 1.0 optical density.

139 cination two-thirds of cattle would have low antibody titres (< 70% protection threshold).

140 An increased anti-Cp antibody titre may be a predictor for further adverse ca

141 erpesvirus (KSHV) DNA in blood and increased antibody titres may indicate KSHV reactivation, while th

142 Detectable KSHV DNA in blood and increased antibody titres may indicate KSHV reactivation, while tr

143 For example, parasite loads and antibody titres may vary over the course of an infection

144 The effects of supplementation on mean DTP antibody titres measured in blood samples collected from

145 esent an analysis of pre- and post-infection antibody titres measured using the PRNT, collected from

146 ipants who received a third dose of vaccine, antibody titres (measured in 73 [81%] participants for w

147 by CD4 and CD8 cells, as well as significant antibody titres, measured by enzyme-linked immunosorbent

148 We present data on multiple virus and antibody titres measurements recorded sequentially durin

149 concentrations and pseudovirus neutralising antibody titres might reflect a diminished serological r

150 was seroconversion, defined as convalescent antibody titres more than or equal to four-fold higher t

151 accine elicited haemagglutination inhibition antibody titres more than tenfold higher than those from

152 ody binding to HIV-infected cells, peak ADCC antibody titres, NK cell-mediated ADCC and antibody-medi

153 viral infection, with declining neutralizing antibody titres observed after an initial peak, and that

154 or greater than the WHO-specified protective antibody titre of 0.5 IU/mL.

155 An anti-circumsporozoite antibody titre of 121 EU/mL (98-153) was estimated to pr

156 ed as a rabbit complement serum bactericidal antibody titre of 8 or higher, with the estimand, given

157 00 vaccinees developed a rise in neutralisng antibody titre of more than four-fold.

158 device injection induced virus neutralising antibody titres of 0.5 IU/mL or more across dose levels

159 Opsonophagocytic antibody titres of 1 in 8 or higher did not predict prot

160 years' duration, had acetylcholine receptor antibody titres of 1.00 nmol/L or higher (or concentrati

161 nza plasma with haemagglutination inhibition antibody titres of 1:80 or more to the infecting strain.

162 acute sera antibody titres, and convalescent antibody titres of 40 or higher.

163 We used antibody titres of Ha-Nam cohort participants to estimat

164 these nine participants, virus neutralising antibody titres of more than 0.5 IU/mL were maintained i

165 ne, nine participants had virus neutralising antibody titres of more than 0.5 IU/mL.

166 l antibody titres, household composition and antibody titres of other members in the same household a

167 with a seven times increase in anti-H1 stalk antibody titres on day 29.

168 recipients (including both low and high Ad5 antibody titres) on whose specimens this testing was don

169 duals living in households with high average antibody titres, or households with more adults, had a r

170 of antibody kinetics that generates expected antibody titres over time.

171 g and resultant induction of low anti-vector antibody titres permitted repeated use of the same adeno

172 ferences in viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines and blood-cell phenoty

173 Waning anti-circumsporozoite antibody titres predict the duration of efficacy against

174 likelihood of achieving transplantation, ABO antibody titre prior to antibody removal and amount of T

175 se of BNT162b2 contained higher neutralizing antibody titres, providing cross-protection against Omic

176 les identified by finger prick in the lowest antibody titre quarter varied among LFIAs.

177 the household contacts, whereas vibriocidal antibody titres ranked lower.

178 Moreover, the neutralising antibody titre reduction of the recovered patient plasma

179 At month 48, antibody titres remained elevated in all TAK-003 groups

180 shing the contribution of such mechanisms to antibody titres remains challenging because the aggregat

181 nts within 14 days of vaccination and day-28 antibody titres, respectively, analysed by intention to

182 olio vaccines per group assignment and polio antibody titre results to serotypes 1, 2, and 3 at 6, 22

183 te vaccination programme for infants, median antibody titres rose significantly in 1-year-olds.

184 ho were previously infected sustained higher antibody titres than individuals who were uninfected pos

185 otein were better at predicting neutralising antibody titres than those based on nucleocapsid, but pe

186 V2.S induced median pseudovirus neutralizing antibody titres that were 5.0-fold and 3.3-fold lower ag

187 udy volunteers, irrespective of baseline Ad5 antibody titre, the HR of HIV-1 infection between vaccin

188 A steeper age-related rise in IgE antibody titre to dust mite, but no other allergen was a

189 nverse relation between AUC cortisol and IgG antibody titre to the Nanchang strain that was significa

190 Even though antibody titres to Abeta were not high, pathological exa

191 ceived a trivalent influenza vaccine and IgG antibody titres to each strain were measured on days 0,

192 cdotal reports suggest that plasma with high antibody titres to influenza might be of benefit in the

193 arameters of the model using cross-sectional antibody titres to nine different strains spanning 40 ye

194 proportions of children with seroprotective antibody titres to type 1 poliovirus were 168 (98.8%) of

195 ary endpoints were seroconversion and median antibody titres to type 2 poliovirus 4 weeks after vacci

196 t schistosome infection, correlating to high antibody titres towards schistosome antigens with unknow

197 he resulting labelled commensal elicits high antibody titres under conditions of physiologic coloniza

198 f clinical malaria and anti-circumsporozoite antibody titres using a model of anti-circumsporozoite a

199 d with GA for 1-5 years were examined for GA antibody titres using enzyme-linked immunoabsorbent assa

200 resulted in serum half-maximal neutralizing antibody titre values of ~5,000 to XBB.1.5, HK.3.1 and J

201 Antibody titres varied considerably among cohorts.

202 and mucosal humoral responses, neutralising antibody titres, viral antigen structural analysis, and

203 , the geometric mean anti-spike-RBD-specific antibody titre was 218.8 U/mL (SD 122.9) in the continue

204 tive, an increase of more than four times in antibody titre was detected 28 days after they were give

205 hepatitis A virus (HAV), and the increase of antibody titres was monitored weekly until 4 wk after va

206 A similar decline in neutralizing antibody titres was observed in a cohort of 31 seroposit

207 Median binding antibody titres were 2.9-fold and 2.7-fold lower against

208 Antibody titres were also analysed according to sequelae

209 multivariate repeated measures model, lower antibody titres were also significantly associated with

210 2 (86%) participants in the high-dose group; antibody titres were boosted in the two-dose group.

211 Binding and neutralizing antibody titres were correlated with protective efficacy

212 for safety and serial blood collections for antibody titres were done on enrolled participants at mo

213 IgG and neutralising antibody titres were dose-related (p=0.0003 for IgG ELIS

214 RTS,S/AS01-induced anti-circumsporozoite antibody titres were greater in children aged 5-17 month

215 Antibody titres were higher 28 days after vaccination in

216 h titres of HuAb, the four patients with low antibody titres were included in the HuAb negative cohor

217 95% CI -4 to -76), pseudovirus neutralising antibody titres were lower (-67%, -25 to -86), and avidi

218 8 EBOV-glycoprotein-binding and neutralising antibody titres were lower in low-dose versus high-dose

219 collected before and after vaccination, and antibody titres were measured by plaque reduction neutra

220 Antibody titres were measured by use of haemagglutinatio

221 Antibody titres were measured with ELISA.

222 Higher NANP-specific antibody titres were observed in the 5-17 month age grou

223 The rubella and yellow fever antibody titres were reduced by co-administration but th

224 Glycoprotein-B antibody titres were significantly increased in both ser

225 although total antibody and epitope specific antibody titres were variable against the different epit

226 f surface binding are governed by an overall antibody titre, while the two fundamental molecular para

227 orrelated with a decrease in antifungal sIgA antibody titre with affinity to two hyphae-associated vi

228 d reduced pre-induced antigen-specific serum antibody titre with little posttreatment rebound.

229 on or COVID-19 vaccination elicits increased antibody titres with broad neutralisation of Omicron sub

230 IgG and receptor binding domain-specific IgG antibody titres with efficacy in preventing SARS-CoV-2 s

231 ria, and in healthy controls, and correlated antibody titres with hemoglobin.

232 for seroconversion (within a 10% margin) and antibody titres (within two-thirds log2 titres) to polio